Quality of Life With Ivabradine in Patients With Angina Pectoris
Author(s) -
Michał Tendera,
Olivier Chassany,
Roberto Ferrari,
Ian Ford,
Philippe Gabríel Steg,
JeanClaude Tardif,
Kim Fox
Publication year - 2015
Publication title -
circulation cardiovascular quality and outcomes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.692
H-Index - 87
eISSN - 1941-7705
pISSN - 1941-7713
DOI - 10.1161/circoutcomes.115.002091
Subject(s) - ivabradine , medicine , angina , quality of life (healthcare) , placebo , coronary artery disease , confidence interval , cardiology , canadian cardiovascular society , physical therapy , heart rate , myocardial infarction , blood pressure , alternative medicine , nursing , pathology
To explore the effect of ivabradine on angina-related quality of life (QoL) in patients participating in the Study Assessing the Morbidity-Mortality Benefits of the If Inhibitor Ivabradine in Patients with Coronary Artery Disease (SIGNIFY) QoL substudy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom